| Literature DB >> 25102414 |
Abstract
Each year in the United States, an estimated 100,000 deaths could be prevented if persons received recommended clinical preventive care. The Affordable Care Act has reduced cost as a barrier to care by expanding access to insurance and requiring many health plans to cover certain recommended preventive services without copayments or deductibles. To establish a baseline for the receipt of these services and to begin monitoring the effects of the law, CDC analyzed responses from persons aged ≥18 years in the National Health Interview Survey (NHIS) for the years 2011 and 2012 combined. This report summarizes the findings for six services covered by the Affordable Care Act. Among the six services examined, three were received by less than half of the persons for whom they were recommended (testing for human immunodeficiency virus [HIV] and vaccination for influenza and zoster [shingles]). Having health insurance or a higher income was associated with higher rates of receiving these preventive services, affirming findings of previous studies. Securing health insurance coverage might be an important way to increase receipt of clinical preventive services, but insurance coverage is not all that is needed to ensure that everyone is offered and uses clinical services proven to prevent disease. Greater awareness of Affordable Care Act provisions among public health professionals, partners, health care providers, and patients might help increase the receipt of recommended services.Entities:
Mesh:
Year: 2014 PMID: 25102414 PMCID: PMC4584657
Source DB: PubMed Journal: MMWR Morb Mortal Wkly Rep ISSN: 0149-2195 Impact factor: 17.586
Comparison of recommendations from the United States Preventive Services Task Force (USPSTF) and the Advisory Committee on Immunization Practices (ACIP) with questions regarding six recommended clinical preventive services in the National Health Interview Survey (NHIS) — United States, 2011–2012
| Clinical preventive service (age group) | Recommendation | Question to NHIS participants | Key distinctions for this analysis of use of recommended services |
|---|---|---|---|
| HIV test (age 18–65 years) | HIV infection screening is recommended for persons aged 15–65 years. Screening is recommended for other age groups at increased risk. Recommended screening interval for the general population is not specified. | To adults aged ≥18 years: “Except for tests you may have had as part of blood donations, have you ever been tested for HIV?” | NHIS asks this question to those aged ≥18 years. Those aged 15–17 years are not included in the analysis. |
| Smoking cessation discussion (age ≥18 years) | Tobacco cessation interventions are recommended for those who use tobacco products. A recommended screening interval for the general population is not specified. | To adults aged ≥18 years who currently smoke cigarettes every day or some days: “During the past 12 months, has a doctor or other health professional talked to you about your smoking?” | Adults who use tobacco only in forms other than cigarettes are not included in the analysis. |
| Influenza vaccination (age ≥18 years) | Annual vaccination against influenza is recommended for all persons aged ≥6 months. | To adults aged ≥18 years: “During the past 12 months, have you had a flu shot?” and “During the past 12 months, have you had a flu vaccine sprayed in your nose by a doctor or other health professional?” A “yes” response to either question is coded as vaccination received. | This analysis focuses on adults aged ≥18 years. |
| Pneumococcal vaccination (age ≥65 years) | Pneumococcal vaccination is recommended for all persons aged ≥65 years and for persons with certain other risk factors aged <65 years. | “Have you ever had a pneumonia shot?” | This analysis focuses on those aged ≥65 years. |
| Tetanus vaccination (age ≥19 years) | Vaccination with Td booster (or 1-time dose of Tdap) for all adults aged ≥19 years. | To adults aged ≥18 years: “Have you received a tetanus shot in the past 10 years?” | This analysis focuses on those aged ≥19 years for consistency with the recommendation for adults. |
| Zoster (shingles) vaccination (age ≥60 years) | Zoster vaccination is recommended for adults aged ≥60 years. | To adults aged ≥50 years: “Have you ever had the zoster or shingles vaccine, also called Zostavax?” | This analysis focuses on those aged ≥60 years for consistency with the recommendation for adults. |
Abbreviations: HIV = human immunodeficiency virus; Td = tetanus and diphtheria; Tdap = tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis.
Source: USPSTF.
At any age.
Source: ACIP.
Percentage of adults in the recommended populations who received six clinical preventive services, by health insurance status — National Health Interview Survey, United States, 2011–2012
| Clinical preventive service (age group) | Insured receiving service | Uninsured receiving service | Prevalence ratio, insured/uninsured | (95% CI) | Total receiving service | |||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
| ||||||||
| No. | % | (95% CI) | No. | % | (95% CI) | % | (95% CI) | |||
| HIV test (ever) (age 18–65 years) | 40,823 | 41.5 | (40.7–42.2) | 11,641 | 43.1 | (41.9–44.3) | 1.0 | (0.9–1.0) |
|
|
| Smoking cessation discussion (within 12 mos) (age ≥18 years) | 8,935 | 59.1 | (58.0–60.3) | 3,497 | 32.7 | (31.1–34.4) | 1.8 | (1.7–1.9) |
|
|
| Influenza vaccination (within 12 mos) (age ≥18 years) | 54,217 | 44.2 | (43.6–44.7) | 11,888 | 14.7 | (13.9–15.4) | 3.0 | (2.9–3.2) |
|
|
| Pneumococcal vaccination (ever) (age ≥65 years) | 13,585 | 61.7 | (60.6–62.7) | 113 | 18.1 | (9.1–27.0) | 3.4 | (2.1–5.6) |
|
|
| Tetanus vaccination (within 10 years) (age ≥19 years) | 51,872 | 63.7 | (63.0–64.3) | 11,431 | 53.7 | (52.6–54.8) | 1.2 | (1.2–1.2) |
|
|
| Zoster vaccination (ever) (age ≥60 years) | 18,297 | 18.4 | (17.6–19.2) | 868 | 6.3 | (4.2–8.4) | 2.9 | (2.1–4.1) |
|
|
Abbreviations: CI = confidence interval; HIV = human immunodeficiency virus.
Generalized linear modeling was used to identify statistical significance of differences between insured and uninsured persons receiving service.
p<0.015.
p<0.001.
Percentage of adults in the recommended populations who received six clinical preventive services, by family income level — National Health Interview Survey, United States, 2011–2012
| Clinical preventive service (age group) | Income >200% FPL receiving service | Income ≤200% FPL receiving service | Prevalence ratio, higher income/lower income | (95% CI) | ||||
|---|---|---|---|---|---|---|---|---|
|
|
| |||||||
| No. | % | (95% CI) | No. | % | (95% CI) | |||
| HIV test (ever) (age 18–65 years) | 31,948 | 40.2 | (39.4–40.9) | 25,815 | 44.6 | (43.5–45.7) | 0.9 | (0.9–0.9) |
| Smoking cessation discussion (within 12 mos) (age ≥18 years) | 6,068 | 53.5 | (52.2–54.8) | 6,404 | 50.4 | (48.9–51.9) | 1.1 | (1.0–1.1) |
| Influenza vaccination (within 12 mos) (age ≥18 years) | 40,110 | 42.8 | (42.2–43.4) | 26,201 | 33.4 | (32.6–34.3) | 1.3 | (1.3–1.3) |
| Pneumococcal vaccination (ever) (age ≥65 years) | 8,268 | 64.4 | (63.1–65.6) | 5,449 | 56.2 | (54.5–57.9) | 1.1 | (1.1–1.2) |
| Tetanus vaccination (within 10 years) (age ≥19 years) | 38,893 | 65.0 | (64.4–65.7) | 24,840 | 56.6 | (55.7–57.5) | 1.1 | (1.1–1.2) |
| Zoster vaccination (ever) (age ≥60 years) | 12,025 | 21.4 | (20.4–22.4) | 7,177 | 11.3 | (10.3–12.3) | 1.9 | (1.7–2.1) |
Abbreviations: CI = confidence interval; HIV = human immunodeficiency virus; FPL = federal poverty level.
Generalized linear modeling was used to identify statistical significance of differences betweeen persons at higher income level and lower income level receiving service.
p<0.001.
p<0.005.
Percentage of adults in the recommended populations who received six clinical preventive services, by source of health insurance coverage — National Health Interview Survey, United States, 2011–2012
| Clinical preventive service (age group) | Private insurance receiving service | Only public insurance receiving service | Prevalence ratio, private/public | (95% CI) | ||||
|---|---|---|---|---|---|---|---|---|
|
|
| |||||||
| No. | % | (95% CI) | No. | % | (95% CI) | |||
| HIV test (ever) (age 18–65 years) | 31,605 | 38.6 | (37.8–39.3) | 9,218 | 53.0 | (51.6–54.3) | 0.7 | (0.7–0.8) |
| Smoking cessation discussion (within 12 mos) (age ≥18 years) | 5,399 | 55.3 | (53.9–56.8) | 3,535 | 65.8 | (64.0–67.5) | 0.8 | (0.8–0.9) |
| Influenza vaccination (within 12 mos) (age ≥18 years) | 38,470 | 42.4 | (41.8–43.1) | 15,738 | 48.9 | (47.9–49.9) | 0.9 | (0.8–0.9) |
| Pneumococcal vaccination (ever) (age ≥65 years) | 6,807 | 66.1 | (64.8–67.4) | 6,769 | 56.9 | (55.3–58.4) | 1.2 | (1.1–1.2) |
| Tetanus vaccination (within 10 years) (age ≥19 years) | 36,917 | 65.7 | (65.1–66.4) | 14,946 | 57.9 | (56.9–58.9) | 1.1 | (1.1–1.2) |
| Zoster vaccination (ever) (age ≥60 years) | 10,305 | 20.4 | (19.4–21.4) | 7,984 | 15.7 | (14.6–16.7) | 1.3 | (1.2–1.4) |
Abbreviations: CI = confidence interval; HIV = human immunodeficiency virus.
Generalized linear modeling was used to identify statistical significance of differences between persons with private insurance and only public insurance.
p<0.05.
p<0.001.